FLT4 and skin cancer: Also, based on a current database analysis of the VEGF-C/VEGFR-3 triggered KRAS/MAPK-YAP1/Slug signaling in skin cancer progression, a unique anti-VEGFR-3 peptide was discovered able to abrogate the process (25).